Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $43.0900 (-1.53%) ($43.0900 - $43.0900) on Wed. Jul. 14, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.17% (three month average) | RSI | 63 | Latest Price | $43.0900(-1.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.1% a day on average for past five trading days. | Weekly Trend | EDIT advances 2.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(67%) IWO(62%) IWC(61%) IBUY(59%) IWM(58%) | Factors Impacting EDIT price | EDIT will decline at least -2.585% in a week (0% probabilities). VIXM(-33%) UUP(-16%) VXX(-12%) TBT(-6%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.585% (StdDev 5.17%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $44.29 | 5 Day Moving Average | $45.54(-5.38%) | 10 Day Moving Average | $48.67(-11.46%) | 20 Day Moving Average | $44.29(-2.71%) | To recent high | -24.5% | To recent low | 37.4% | Market Cap | $2.676b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |